NOVAVAX INC
For the period ended Jun 18, 2026. Filed Apr 27, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 18, 2026 · Filed Apr 27, 2026
Contents
Objectives of the Executive Compensation Program
The Compensation Committee believes the compensation for our executive officers should be designed to attract, retain, and reward highly qualified executive officers responsible for the success of Novavax and should be determined within a framework that rewards performance and aligns the interests of the executive officers with the interests of the Company’s stockholders.
Within this overall philosophy, the Compensation Committee’s objectives are to:
| Attract and retain appropriately qualified and industry experienced executives | Align executive compensation with competitive market practices | Align executives’ interests with those of our stockholders | Reward executives for meeting the strategic goals and objectives of the Company | Reward strong individual performance |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.